pros and cons of glp 1 agonists The Benefits GLP-1 Therapy: Beyond Weight Loss Pros & cons of GLP-1

Other combinations of entero-pancreatic hormones including cagrisema (GLP-1/amylin RA) and the triple agonist retatrutide (GLP-1/GIP/glucagon RA) have also progressed to phase 3 trials as obesity treatments and early data suggests that may lead to even greater WL than tirzepatide

The WHO released new guidance on GLP-1 medications for adults with obesity, recommending their long-term, continuous usewhen clinically appropriate.

Although evidence from clinical trials has shown GLP-1 RAs to be safe and efficacious in people living with T2DM and renal impairment, their use is uncommon in this patient population

Dan McKees proposed fiscal year 2027 budget would remove GLP-1 drugs from Rhode Islands Medicaid formulary for weight loss, saving $6.3 million in general revenue

Satiety regulation (reduces appetite, aiding in weight loss)

SUPPORT WEIGHT MANAGEMENT: In clinical studies Morosil red orange extract is shown to support fat reduction, reduce BMI and combat visceral fat (in combination with diet and exercise).*